Drug:
Reaction: PRURITUS
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26564980 |
41 | 2 | |
Tachycardia, Tongue pruritus, Pruritus, Pruritus, Infusion related reaction, Throat tightness, |
||||
CARBOPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, IRON SUCROSE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, PEMBROLIZUMAB, FAMOTIDINE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 202 | 26565126 |
2 | ||
Metastatic malignant melanoma, HER2 positive breast cancer, Pruritus, |
||||
DABRAFENIB, AMOXICILLIN, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 203 | 26565276 |
68 | 2 | |
Intestinal obstruction, Pruritus, Fatigue, Diarrhoea, Sleep disorder, Pollakiuria, |
||||
USTEKINUMAB-STBA, |
||||
| 204 | 26565459 |
55 | 1 | |
Swelling of eyelid, Erythema, Pruritus, |
||||
LENALIDOMIDE, |
||||
| 205 | 26565714 |
79 | 1 | |
Chest discomfort, Pruritus, Wheezing, Urticaria, Cough, Hypoxia, Pruritus, Injection related reaction, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 206 | 26565732 |
82 | 2 | |
Cellulitis, Diarrhoea, Gait disturbance, Pruritus, |
||||
RITLECITINIB, |
||||
| 207 | 26565944 |
66 | 2 | |
Pruritus, Rash, Urticaria, Pruritus, |
||||
PEMIVIBART, |
||||
| 208 | 26566429 |
49 | 1 | |
Pruritus, Skin abrasion, Scratch, Therapy interrupted, Withdrawal syndrome, |
||||
CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 209 | 26569069 |
76 | 1 | |
Cough, Dyspnoea, Hypotension, Pruritus, Rash, Urticaria, |
||||
| 210 | 26569767 |
63 | 1 | |
Abdominal pain, Agitation, Eczema, Insomnia, Pruritus, Psoriasis, Rash, |
||||
GALCANEZUMAB-GNLM, |
||||
| 211 | 26548974 |
GB |
64 | |
Skin exfoliation, Skin weeping, Skin irritation, Swelling, Pain, Rash erythematous, Pruritus, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 212 | 26548996 |
CA |
74 | 2 |
Asthenia, Dizziness, Drug ineffective, Drug intolerance, Nausea, Pruritus, Spinal disorder, |
||||
RITUXIMAB, RITUXIMAB, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB-ADAZ, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 213 | 26549024 |
CA |
38 | |
Asthma, Blood pressure increased, Blood urea decreased, Body mass index increased, Body temperature decreased, Dyspnoea, Forced expiratory volume decreased, Glomerular filtration rate decreased, Malaise, Middle insomnia, Obesity, Obstructive airways disorder, Oropharyngeal pain, Pain, Pneumonia, Psoriatic arthropathy, Reversible airways obstruction, Sensitivity to weather change, Swelling, Swelling face, Total lung capacity decreased, Weight decreased, Pyrexia, Urticaria, Sinusitis, Pruritus, Arthralgia, Cardiac failure congestive, Diarrhoea, Nasopharyngitis, Influenza, Cough, Anaphylactic reaction, Drug hypersensitivity, Weight increased, Respiratory disorder, Product dose omission issue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, SECUKINUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CICLESONIDE, DIPHENHYDRAMINE HYDROCHLORIDE, CICLESONIDE, RABEPRAZOLE, RANITIDINE, SERTRALINE HYDROCHLORIDE, MONTELUKAST SODIUM, |
||||
| 214 | 26549134 |
US |
23 | 2 |
Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 215 | 26549163 |
US |
45 | 1 |
Pruritus, Dry skin, Eye pruritus, Dry eye, Injection site swelling, Skin exfoliation, Injection site pain, Injection site haemorrhage, |
||||
DUPILUMAB, |
||||
| 216 | 26549170 |
US |
48 | 1 |
Pruritus, |
||||
DUPILUMAB, DUPILUMAB, CERTOLIZUMAB PEGOL, |
||||
| 217 | 26549173 |
US |
63 | 2 |
Rash macular, Erythema, Dry skin, Pruritus, International normalised ratio decreased, |
||||
DUPILUMAB, |
||||
| 218 | 26549175 |
US |
25 | 2 |
Dermatitis atopic, Pruritus, Rash, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 219 | 26549190 |
US |
8 | 2 |
Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 220 | 26549209 |
US |
15 | 1 |
Pruritus, Injection site pain, |
||||
DUPILUMAB, |
||||
| 221 | 26549211 |
US |
39 | 1 |
Skin ulcer, Condition aggravated, Pruritus, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 222 | 26549216 |
US |
60 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 223 | 26549217 |
US |
68 | 2 |
Dermatitis, Rash pruritic, Skin swelling, Erythema, Pruritus, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 224 | 26549224 |
US |
62 | 1 |
Rash erythematous, Skin burning sensation, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 225 | 26549231 |
US |
60 | 2 |
Rhinorrhoea, Pruritus, Ocular hyperaemia, |
||||
DUPILUMAB, |
||||
| 226 | 26549237 |
US |
39 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Dermatitis, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 227 | 26549243 |
US |
82 | 2 |
Nausea, Pruritus, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, |
||||
| 228 | 26549249 |
US |
91 | 2 |
Dry skin, Insomnia, Pruritus, |
||||
DUPILUMAB, |
||||
| 229 | 26549250 |
US |
39 | 2 |
Pruritus, Product use in unapproved indication, |
||||
BELUMOSUDIL, BACLOFEN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, NEBIVOLOL HYDROCHLORIDE, CLOTRIMAZOLE, DRS. CLOTRIMAZOLE, FAMILY WELLNESS CLOTRIMAZOLE, CLOTRIMAZOLE TOPICAL, ISAVUCONAZONIUM SULFATE, FAMOTIDINE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MAGNESIUM OXIDE, TIRZEPATIDE, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, NORETHINDRONE, ROSUVASTATIN, SERTRALINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ERGOCALCIFEROL, |
||||
| 230 | 26549268 |
US |
48 | 2 |
Thyroidectomy, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 231 | 26549276 |
US |
58 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 232 | 26549291 |
US |
20 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 233 | 26549294 |
US |
71 | 1 |
Pruritus, Product dose omission issue, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 234 | 26549296 |
US |
37 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 235 | 26549298 |
US |
32 | 2 |
Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 236 | 26549299 |
US |
77 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 237 | 26549305 |
US |
47 | 1 |
Sleep disorder, Dermatitis atopic, Skin haemorrhage, Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 238 | 26549307 |
US |
2 | |
Sneezing, Pruritus, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 239 | 26549320 |
US |
59 | 2 |
Eczema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 240 | 26549331 |
US |
76 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 241 | 26549333 |
US |
32 | 2 |
Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 242 | 26549335 |
US |
88 | 2 |
Erythema, Pruritus, Blister, |
||||
DUPILUMAB, |
||||
| 243 | 26549345 |
US |
43 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 244 | 26549351 |
US |
74 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 245 | 26549352 |
US |
29 | 2 |
Injection site erythema, Injection site pain, Muscle tightness, Anxiety, Musculoskeletal stiffness, Erythema, Dermatitis atopic, Pruritus, Swelling, Dry skin, Wound, |
||||
DUPILUMAB, |
||||
| 246 | 26549354 |
US |
2 | |
Pruritus, Dermatitis atopic, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 247 | 26549355 |
US |
38 | 1 |
Eczema, Pruritus, Sleep disorder due to a general medical condition, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 248 | 26549358 |
US |
11 | 1 |
Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 249 | 26549359 |
US |
21 | 1 |
Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 250 | 26549366 |
US |
8 | 2 |
Infection, Injection site pain, Dermatitis atopic, Dry skin, Pruritus, Swelling, Burning sensation, |
||||
DUPILUMAB, |
||||
| 251 | 26549367 |
US |
2 | |
Headache, Eye pruritus, Pruritus, |
||||
DUPILUMAB, |
||||
| 252 | 26549394 |
US |
28 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, |
||||
DUPILUMAB, |
||||
| 253 | 26549398 |
55 | ||
Rash, Pruritus, Fatigue, Off label use, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, HYDROXYZINE, |
||||
| 254 | 26549399 |
US |
64 | 1 |
Dermatitis atopic, Pruritus, Skin burning sensation, Pain of skin, Injection site pain, |
||||
DUPILUMAB, |
||||
| 255 | 26549402 |
US |
51 | 1 |
Pruritus, Sleep disorder, Skin fissures, Dry skin, |
||||
DUPILUMAB, |
||||
| 256 | 26549409 |
US |
67 | 1 |
Rash, Pruritus, Tinea pedis, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 257 | 26549422 |
US |
1 | |
Pruritus, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 258 | 26549426 |
US |
52 | 1 |
Pruritus, Skin haemorrhage, Skin weeping, Skin fissures, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 259 | 26549432 |
US |
79 | 2 |
Pruritus, Intentional dose omission, |
||||
DUPILUMAB, DUPILUMAB, PEMBROLIZUMAB, |
||||
| 260 | 26549439 |
US |
37 | 2 |
Urticaria, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 261 | 26549446 |
US |
70 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Eczema, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 262 | 26549463 |
US |
73 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 263 | 26549475 |
US |
33 | 2 |
Sleep disorder, Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 264 | 26549479 |
US |
50 | 2 |
Pruritus, Skin exfoliation, Dyspnoea, Eye pruritus, Pruritus, Rash, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 265 | 26549487 |
US |
1 | |
Skin exfoliation, Rash, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 266 | 26549491 |
US |
71 | 2 |
Neurodermatitis, Pruritus, |
||||
DUPILUMAB, |
||||
| 267 | 26549501 |
US |
67 | 1 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 268 | 26549509 |
US |
71 | 1 |
Dermatitis atopic, Pruritus, Therapeutic response shortened, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 269 | 26549515 |
US |
83 | 2 |
Pruritus, Rash, |
||||
DUPILUMAB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 270 | 26549516 |
US |
71 | 2 |
Skin lesion, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 271 | 26549521 |
US |
31 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 272 | 26549522 |
US |
73 | 1 |
Eczema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 273 | 26549523 |
US |
64 | 2 |
Pruritus, Sleep disorder, Dry skin, Product dose omission issue, Skin weeping, |
||||
DUPILUMAB, |
||||
| 274 | 26549530 |
US |
1 | |
Pruritus, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 275 | 26549531 |
US |
1 | |
Injection site pain, Eczema, Pruritus, Intentional dose omission, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 276 | 26549535 |
US |
84 | 2 |
Eczema, Pruritus, |
||||
DUPILUMAB, NEMOLIZUMAB-ILTO, |
||||
| 277 | 26549549 |
US |
55 | 2 |
Sinusitis, Hypersensitivity, Pruritus, Sinus polyp, Condition aggravated, Asthma, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 278 | 26549551 |
US |
54 | 1 |
Condition aggravated, Rash erythematous, Pruritus, Skin burning sensation, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 279 | 26549554 |
US |
61 | 1 |
Neurodermatitis, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 280 | 26549574 |
US |
29 | 2 |
Eczema, Erythema, Pruritus, Dry skin, Rash, Haemorrhage, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 281 | 26549593 |
US |
29 | 2 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 282 | 26549595 |
US |
27 | 2 |
Food allergy, Paraesthesia oral, Allergy to animal, Pruritus, Sneezing, Flushing, Erythema, Neck pain, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 283 | 26549604 |
US |
1 | 2 |
Dermatitis, Ocular hyperaemia, Periorbital inflammation, Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 284 | 26549616 |
US |
43 | 2 |
Retching, Food refusal, Dysphagia, Injection site urticaria, Pruritus, Injection site erythema, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 285 | 26549627 |
US |
85 | 2 |
Pruritus, Blister, |
||||
DUPILUMAB, |
||||
| 286 | 26549662 |
US |
7 | 1 |
Insomnia, Eczema, Pruritus, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 287 | 26549670 |
US |
89 | 1 |
Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 288 | 26549682 |
US |
23 | 2 |
Dermatitis atopic, Pruritus, Product dose omission issue, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 289 | 26549694 |
ZA |
25 | 2 |
Wheezing, Pruritus, Rash, Cough, Dyspnoea, |
||||
CISPLATIN, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 290 | 26549695 |
US |
27 | 1 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 291 | 26549709 |
US |
12 | 2 |
Eczema, Pruritus, |
||||
DUPILUMAB, TRALOKINUMAB-LDRM, |
||||
| 292 | 26549725 |
US |
1 | |
Skin irritation, Erythema, Pruritus, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 293 | 26549738 |
2 | ||
Pruritus, |
||||
| 294 | 26549741 |
US |
1 | |
Pruritus, |
||||
GUSELKUMAB, |
||||
| 295 | 26549869 |
CN |
68 | 1 |
Pruritus, Papule, Off label use, |
||||
| 296 | 26546740 |
US |
56 | 1 |
Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 297 | 26546746 |
US |
25 | 2 |
Pruritus, Dry skin, Injection site pain, |
||||
DUPILUMAB, |
||||
| 298 | 26546792 |
US |
70 | 2 |
Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 299 | 26546793 |
US |
38 | 2 |
Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 300 | 26546826 |
US |
2 | |
Hordeolum, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, SPIRONOLACTONE, TIRZEPATIDE, ERYTHROMYCIN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28